Re: you won’t see anyone buying this

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

tada

Rank: President [?]

Points: 7677 [?]

Votes: 40 Score: 3.4 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: you won’t see anyone buying this

in response to

Re: you won’t see anyone buying this

KOO-KOO2

posted on Dec 07, 2023 06:21PM

KK2, fuzzyjr, Temsamany - the price of the ZHCLF shares on the market is not what Zenith Capital Corp is about. It's a royalty company. If royalties begin to be paid someday, understand that those royalties will be less by about 36% today than they would have been in 2021. Temsamany in your case the shares you received in 2013 are now diluted by over 300%. That's a wow.